What is the cause of a white cloudy substance in a urine catheter tube that has been in place for one month?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

White Cloudy Material in Long-Term Urinary Catheter

The white cloudy material in a catheter that has been in place for one month is most likely crystalline biofilm encrustation caused by urease-producing bacteria, particularly Proteus mirabilis, which elevates urine pH and precipitates calcium and magnesium phosphate crystals. 1, 2

Understanding the Problem

Biofilm Formation and Encrustation

  • Urinary catheters inevitably develop biofilms on both inner and outer surfaces once inserted, with bacteria colonizing the catheter and producing extracellular products that appear as white cloudy material. 3, 1

  • The white cloudiness specifically represents crystalline biofilm—a combination of bacterial colonies embedded in calcium and magnesium phosphate crystals that precipitate when urease-producing bacteria (especially Proteus mirabilis) convert urea to ammonia, raising urine pH. 2, 4

  • Approximately 50% of long-term catheterized patients experience catheter encrustation and blockage from this crystalline biofilm formation. 4, 2

Timeline Considerations

  • With a catheter in place for one month, biofilm formation is expected and universal—all patients with indwelling catheters ultimately develop bacteriuria and biofilm if the catheter remains in place long enough. 3

  • Bacterial acquisition occurs at a rate of 3-5% per catheter day, meaning by one month, colonization and biofilm formation are essentially inevitable. 3

Clinical Significance and Risks

Immediate Concerns

  • Crystalline biofilm can progress to complete catheter blockage, causing urine retention, bladder distension, kidney reflux, incontinence from urine leaking around the catheter, and potentially serious complications including pyelonephritis, septicemia, and endotoxic shock. 2

  • The biofilm protects bacteria from antimicrobials and the host immune response, making infections persistent and resistant to treatment. 3, 5

  • Encrustation can initiate bladder stone formation—most patients with recurrent catheter encrustation develop bladder stones where P. mirabilis establishes stable residence and becomes extremely difficult to eliminate. 2

Assessment for Symptomatic Infection

  • Do not treat the presence of bacteria or cloudiness alone—screening for and treating asymptomatic bacteriuria in long-term catheterized patients is not recommended. 3

  • Only treat if the patient has symptoms of catheter-associated UTI: fever, new-onset suprapubic pain, costovertebral angle tenderness, acute hematuria, rigors, or altered mental status in the absence of other causes. 3, 6

  • If symptomatic UTI is suspected, obtain urine culture before starting antimicrobials, as catheter-associated infections involve a wide spectrum of organisms with increased antimicrobial resistance. 6

Management Approach

Catheter Replacement

  • Replace the catheter now if there are any signs of blockage, reduced urine flow, leakage around the catheter, or symptoms of infection. 3

  • When treating symptomatic UTI in a catheterized patient, changing the catheter before collecting urine improves culture accuracy and may improve antibiotic response by removing the biofilm that serves as a nidus for reinfection. 5

  • There is insufficient evidence to recommend routine catheter changes at fixed intervals (such as monthly) solely to prevent encrustation, though this practice is common. 3

Prevention Strategies

  • Evaluate daily whether the catheter is still necessary and remove it as soon as possible—this is the most effective way to reduce catheter-associated complications. 3, 7

  • Maintain a closed drainage system with the drainage bag always kept below bladder level to minimize bacterial ascent. 7

  • Do not add antimicrobials or antiseptics to the drainage bag, as this does not reduce bacteriuria or infection rates. 3

  • Do not use prophylactic systemic antimicrobials or bladder irrigation to prevent catheter-associated bacteriuria, as this promotes antimicrobial resistance without proven benefit. 3

Common Pitfalls to Avoid

  • Do not treat asymptomatic bacteriuria or cloudiness alone with antibiotics—this only promotes resistant organisms without clinical benefit and does not prevent symptomatic UTI. 3

  • Do not assume all white material is infection requiring antibiotics—it may represent sterile crystalline deposits or asymptomatic colonization. 4, 2

  • Do not delay catheter change if blockage is developing—waiting can lead to acute urinary retention and serious complications including pyelonephritis and sepsis. 2

  • Recognize that silver-coated or antimicrobial-coated catheters are equally vulnerable to crystalline biofilm encrustation and blockage. 2

References

Research

Bacterial biofilm formation on indwelling urethral catheters.

Letters in applied microbiology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Urinary catheter biofilm infections].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2008

Research

Role of biofilm in catheter-associated urinary tract infection.

American journal of infection control, 2004

Guideline

Urine Culture in Catheter-Associated UTI with Recent Suprapubic Catheter Change

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Indwelling Catheters for Controlling Candiduria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.